What is a rock inhibitor?: Decoding a Unique Pharmacological Pathway
•
4 min read
First introduced into clinical ophthalmology in Japan in 2014, a **rock inhibitor** is a class of compounds that targets the Rho/ROCK signaling pathway, a crucial regulator of cellular functions like migration, adhesion, and contraction. This innovative pharmacological approach has broad therapeutic potential by interfering with fundamental cell signaling processes.
